Observational Study to Observe the Safety of Levemir® Treatment in Patients With Type 2 Diabetes
Status:
Completed
Trial end date:
2010-05-01
Target enrollment:
Participant gender:
Summary
This observational study is conducted in Europe. The study aims to observe the incidence of
serious adverse drug reactions in subjects with type 2 diabetes during Levemir® treatment.